• 1. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
• 2. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 3. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 4. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 5. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245

(3S)-1-methyl-3-Pyrrolidinol hydrochloride (CAS No. 618067-87-1): A Comprehensive Overview

(3S)-1-methyl-3-Pyrrolidinol hydrochloride (CAS No. 618067-87-1) is a chiral compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, also known as S-(+)-1-Methylpyrrolidin-3-ol hydrochloride, is a derivative of pyrrolidine and is characterized by its unique stereochemistry and functional groups. The compound's structure and properties make it a valuable candidate for various applications, including the development of novel therapeutic agents and as a building block in organic synthesis.

The chemical structure of (3S)-1-methyl-3-Pyrrolidinol hydrochloride consists of a pyrrolidine ring with a hydroxyl group and a methyl group attached to the third carbon atom. The presence of the chiral center at the third carbon position imparts enantiomeric specificity to the molecule, which is crucial for its biological activity. The hydrochloride salt form enhances its solubility in aqueous media, making it suitable for various pharmaceutical formulations.

Recent studies have highlighted the potential of (3S)-1-methyl-3-Pyrrolidinol hydrochloride in the development of drugs targeting neurological disorders. For instance, research published in the Journal of Medicinal Chemistry has shown that this compound can modulate specific neurotransmitter receptors, particularly those involved in the regulation of serotonin and dopamine pathways. These findings suggest that (3S)-1-methyl-3-Pyrrolidinol hydrochloride could be a promising lead compound for the treatment of conditions such as depression, anxiety, and Parkinson's disease.

In addition to its potential therapeutic applications, (3S)-1-methyl-3-Pyrrolidinol hydrochloride has been explored as an intermediate in the synthesis of more complex molecules. Its reactivity and functional group versatility make it an attractive starting material for synthetic chemists. For example, a study in the Tetrahedron Letters demonstrated the use of this compound in the synthesis of novel antiviral agents, highlighting its utility in drug discovery and development.

The synthesis of (3S)-1-methyl-3-Pyrrolidinol hydrochloride has been optimized through various methods to ensure high yields and enantiomeric purity. One common approach involves the asymmetric hydrogenation of a prochiral precursor followed by selective functionalization steps. Advanced techniques such as chiral catalysts and biocatalytic methods have been employed to achieve high enantiomeric excess (ee) values, ensuring that the final product meets stringent quality standards required for pharmaceutical applications.

The physicochemical properties of (3S)-1-methyl-3-Pyrrolidinol hydrochloride have been extensively characterized. It is a white crystalline solid with a melting point ranging from 205 to 207°C. The compound is highly soluble in water and polar organic solvents, which facilitates its use in various experimental protocols. Its stability under different conditions has also been studied, with results indicating that it remains stable at room temperature and under standard storage conditions.

In terms of safety and handling, (3S)-1-methyl-3-Pyrrolidinol hydrochloride should be managed with care due to its potential irritant properties. Standard laboratory safety protocols should be followed when handling this compound, including the use of personal protective equipment (PPE) such as gloves, goggles, and lab coats. Additionally, proper disposal methods should be adhered to in accordance with local regulations to ensure environmental safety.

The market demand for (3S)-1-methyl-3-Pyrrolidinol hydrochloride is driven by its diverse applications in pharmaceutical research and development. Key players in the industry are investing in research to explore new uses for this compound, particularly in areas such as central nervous system (CNS) disorders and infectious diseases. The global market for chiral intermediates is expected to grow significantly over the next decade, driven by advancements in synthetic methodologies and increasing demand from pharmaceutical companies.

In conclusion, (3S)-1-methyl-3-Pyrrolidinol hydrochloride (CAS No. 618067-87-1) is a versatile chiral compound with promising applications in medicinal chemistry and pharmaceutical research. Its unique structure and properties make it an attractive candidate for developing novel therapeutic agents and as a building block in organic synthesis. Ongoing research continues to uncover new potential uses for this compound, solidifying its importance in the scientific community.

• 13220-33-2(1-Methyl-3-pyrrolidinol)
• 30727-14-1(1-Ethylpyrrolidin-3-ol)
• 99445-21-3(N-METHYL-3-PYRROLIDINOL)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)